Engineered to simulate real-world occupational exposure to airborne high-temperature insulation fibers and dusts.
High-temperature industrial thermal insulation materials—such as refractory ceramic fibers (RCF), polycrystalline wools (PCW), alkaline earth silicate (AES) wool, and aerogel blankets—are indispensable in heavy industries like metallurgy, petrochemical refining, aerospace, and glass manufacturing. These materials operate in environments exceeding 1000°C, preventing thermal loss and ensuring structural integrity.
However, during their manufacturing, installation, maintenance, and eventual decommissioning, these materials inevitably release micro- and nano-scale fibers and particulate matter into the occupational environment. Because of their physical dimensions and chemical persistence, these airborne fibers can be inhaled deeply into the human respiratory tract, potentially causing chronic inflammation, pulmonary fibrosis, and carcinogenesis.
Regulatory bodies worldwide, including the International Agency for Research on Cancer (IARC) and the European Chemicals Agency (ECHA), place stringent classifications on refractory fibers. This pressure has accelerated the industrial demand for advanced toxicity screening methods.
Historically, *in vivo* animal inhalation studies have been the gold standard for evaluating the toxicity of inhaled fibers. However, *in vivo* testing is highly time-consuming, expensive, and faces significant ethical challenges. Furthermore, standard animal models do not always perfectly mimic human cellular responses to engineered mineral fibers.
This has led to the rapid rise of **In Vitro Cell Exposure** testing systems. By utilizing human lung epithelial cells, macrophages, and multi-cellular co-cultures exposed directly to aerosolized insulation particles at the Air-Liquid Interface (ALI), researchers can accurately simulate human respiratory exposure. This methodology bridges the gap between basic cell culture and complex animal studies, enabling rapid, cost-effective, and physiologically relevant hazard characterization of next-generation thermal insulation materials.
How modern aerosol technology and advanced cell culture techniques are revolutionizing safety assessments.
Traditional *in vitro* toxicity assays involve submerging cells in liquid culture media. However, when evaluating insoluble or fibrous materials like high-temperature insulation dust, submerged models introduce severe artifacts. Fibers aggregate in liquid, settle unevenly, and interact chemically with the media, leading to inaccurate dose-response data.
Modern ALI systems resolve this by growing lung cells on porous membranes. The apical side of the cells is exposed directly to the aerosolized insulation dust, while the basolateral side receives nutrients from the culture medium. This precisely mirrors the physiological conditions of the human alveolar region, ensuring that the physical and chemical properties of the fibers remain unaltered during exposure.
Aerosolizing long, high-aspect-ratio fibers without breaking them or causing system blockages is a major technological hurdle. Current industry trends focus on developing specialized aerosol generators capable of dry dispersion of refractory ceramic fibers and aerogel powders, ensuring a stable, concentration-controlled flow of respirable fibers (typically defined as length > 5 µm and diameter
To establish reliable dose-response relationships, it is critical to know exactly how much mass is deposited per unit area on the cells. Advanced exposure systems now integrate online deposition sensors, such as Quartz Crystal Microbalances (QCM) and spectrophotometric tracking, allowing scientists to monitor dust deposition in real-time down to nanogram resolution.
The human lung defense mechanism relies on interactions between multiple cell types. Current research is rapidly moving towards using co-cultures of human bronchial or alveolar epithelial cells (e.g., A549 or primary cells) with immune cells (macrophages and dendritic cells). This setup enables the study of complex inflammatory cascades, cytokine release, and fibrogenesis markers triggered by high-temperature insulation dust.
Understanding how in vitro cell exposure systems solve real-world industrial safety and R&D challenges.
To bypass the strict regulations on refractory ceramic fibers (RCFs), manufacturers are actively developing biosoluble alkaline earth silicate (AES) wools. These fibers are designed to dissolve rapidly in human lung fluid if inhaled, preventing long-term bio-persistence. *In vitro* cell exposure systems allow R&D teams to screen dozens of chemical formulations in parallel, evaluating both cellular toxicity and dissolution rates in simulated lung fluid under physiological conditions, dramatically shortening the product development cycle.
Silica aerogels are cutting-edge insulation materials with extremely low thermal conductivity. However, handling aerogel blankets releases ultra-fine silica dust and nanoparticles. *In vitro* cell exposure systems are used to determine whether these nanoparticles induce oxidative stress, cytotoxicity, or DNA damage in human lung cells. This data is critical for securing regulatory approvals and designing safe handling guidelines for industrial installers.
Industrial hygiene standards require establishing clear exposure limits for workers. By combining *in vitro* cell exposure data with mathematical lung deposition models, toxicologists can predict human pulmonary responses to specific concentrations of airborne insulation fibers. This computational-experimental hybrid approach provides a scientific basis for setting safe Occupational Exposure Limits without the need for extensive animal testing.
High-temperature insulation materials undergo physical and chemical changes after prolonged exposure to extreme heat (e.g., devitrification of vitreous fibers into crystalline silica at temperatures above 1000°C). Exposure systems can test "aged" or thermally degraded insulation dust collected from industrial furnaces, helping safety managers assess whether old insulation linings pose a higher health risk during maintenance outages than fresh materials.
Beijing Huironghe Technology Co., Ltd. (overseas brand "HRHINS"), founded in 2010 with a registered capital of 10 million yuan, is located in the Beijing Economic-Technological Development Area. The company specializes in the R&D, production, sales, and technical services for inhalation toxicity, genetic toxicity, inhaler testing, aerosol detection, and lab automation systems.
HRHINS has been recognized as a National High-tech Enterprise and designated as a Beijing Municipal Corporate Science and Technology R&D Institution. Additionally, it has received honors such as being a Beijing "Specialized, Refined, Unique, and Innovative" SME, a China Manufacturing Champion Enterprise, and a Beijing Intellectual Property Demonstration Enterprise.
The company occupies over 3000sqm of offices, R&D center and workshops, delivering industry-leading aerosol generation and exposure technologies.

HRHINS holds certifications for the ISO 9001:2015 Quality Management System, ISO 14001:2015 Environmental Management System, ISO 45001:2018 Occupational Health and Safety Management System, and GB/T 29490-2013 Intellectual Property Management System.

In 2018, HRHINS supported the establishment of the Respiratory Toxicology Committee of the Chinese Society of Toxicology and became its founding sponsor. The company also gained council membership in prestigious organizations, including the Chinese Society of Toxicology, the Chinese Environmental Mutagen Society, and the Zhongguancun New Bio-pharmaceutical Industry Alliance.
HRHINS has developed over 60 innovative instruments, including aerosol generators, inhalation systems, fully automated QuEChERS systems, multi-stage cascade impactors, and breathing simulators. The aerosol toxicity instrument line offers a complete suite for studies involving rats, mice, guinea pigs, ferrets, rabbits, dogs, and monkeys. Supported exposure methods are equally comprehensive, covering nose-head, whole-body, airborne infection, and in vitro cell culture exposures.
Crucially, all products—from aerosol generation and detection to sampling and system control—are based on independent intellectual property. These solutions are widely employed by GLP laboratories, safety assessment centers, universities, research institutions, and hospital respiratory departments worldwide.
Explore our full line of advanced exposure systems designed for industrial dust, aerosol, and fiber toxicology research.